Request Trial
12 January 2026NewsCareers

Carpmaels & Ransford builds Munich UPC team with elite hire

An experienced Ex-Hoffmann Eitle litigator, who worked on Sanofi v Amgen, joins the firm's growing UPC team in Munich, Germany.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Careers
MoFo bags IP trial duo with 50 years’ combined experience
11 June 2026   The opportunity to grow a “powerhouse IP litigation practice in the heart of New York” was behind the lateral move of highly experienced litigators to Morrison Foerster.
Careers
Clarivate’s new IP president to ‘usher in next phase of growth’
9 June 2026   The data and intelligence firm appoints the former CEO of CPA Global—which Clarivate bought in 2020—to lead the IP division’s growth, as the global company aims to accelerate AI integration and streamline its core business operations.
Careers
Ex-Kirkland patent litigator jumps to rival firm
8 June 2026   Known for his work on major pharmaceutical patent disputes and landmark SEP cases, the London-based litigator has joined a new firm as partner.


Editor's picks

Hikma v Amarin: Six takeaways from the pivotal ruling
Americas
Hikma v Amarin: Six takeaways from the pivotal ruling
9 June 2026

Editor's picks

Americas
Hikma v Amarin: Six takeaways from the pivotal ruling
9 June 2026
Americas
UK govt backs DeepMind spinout’s $2.1bn plan to ‘solve all disease’ with AI
14 May 2026
Americas
From the courtroom: Hikma v Amarin SCOTUS oral arguments
30 April 2026
Americas
Penile implant maker’s $17m trade secret award unravels
20 April 2026
Biotechnology
Closing the women's health gap offers ‘benefits for all’
7 April 2026
Europe
European patent offices raise fees
2 April 2026

More features

Siemens ordered to recall mammography device across European countries
MoFo bags IP trial duo with 50 years’ combined experience
US biotech fires trade secrets suit at Chinese pharma group
Hikma v Amarin: Six takeaways from the pivotal ruling
Exclusive: ‘When a UPC judge wears their robe, they have no gender’
Clarivate’s new IP president to ‘usher in next phase of growth’
Fed Circ rejects Nexus’ appeal in generics row with biopharma firm
Ex-Kirkland patent litigator jumps to rival firm